| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 11/25/2010 | WO2010134086A1 Medicinal formulation containing selected cytokines |
| 11/25/2010 | US20100298735 Methods For Classifying And Treating Physiologic Brain Imbalances Using Quantitative EEG |
| 11/25/2010 | US20100298279 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology |
| 11/25/2010 | US20100298254 Organ arrest, protection and preservation |
| 11/25/2010 | US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 11/25/2010 | US20100297215 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 11/25/2010 | US20100297107 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 11/25/2010 | US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 11/25/2010 | CA2762574A1 Combinations of immunostimulatory agents, oncolytic virus, and additional anticancer therapy |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR |
| 11/24/2010 | EP2253328A1 Cycloalkyl inhibitors of potassium channel function |
| 11/24/2010 | EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 11/24/2010 | EP2253326A1 Pharmaceutical composition for transnasal administration |
| 11/24/2010 | EP2253321A1 Collyrium for the treatment of conial cornea with "cross-linking" trans-epithelial technique |
| 11/24/2010 | EP2253320A1 Combination of a pyrimidylaminobenzamide and a mTOR kinase inhibitor |
| 11/24/2010 | EP2253319A1 Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. |
| 11/24/2010 | EP2253317A2 Triazol compounds for treating biofilm formation |
| 11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 11/24/2010 | EP2253311A2 Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto |
| 11/24/2010 | EP2252729A1 Biomarkers for head-and-neck cancers and precancers |
| 11/24/2010 | EP2252370A1 Use of lipid-rich nutrition for the treatment of post-operative ileus |
| 11/24/2010 | EP2252327A2 Methods of treating copd |
| 11/24/2010 | EP2252289A1 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 11/24/2010 | EP2252280A1 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis |
| 11/24/2010 | EP2252273A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 11/24/2010 | EP1667719B1 Treatment of gastrointestinal stromal tumors with imatinib and midostaurin |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer |
| 11/24/2010 | EP1496742B1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 11/24/2010 | EP1438418B1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/24/2010 | EP1407784B1 Antitumor agents |
| 11/24/2010 | EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 11/24/2010 | EP1100454B1 Pharmaceutical compositions for managing skin conditions |
| 11/24/2010 | EP0444181B2 C-erbb-2 external domain: gp75 |
| 11/24/2010 | CN1808106B Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance |
| 11/24/2010 | CN101896622A Methods for assaying MC1R variants and mitochondrial markers in skin samples |
| 11/24/2010 | CN101896501A Antibody targeting osteoclast-related protein Siglec-15 |
| 11/24/2010 | CN101896205A Compositions and methods employing NMDA antagonists for achieving an anesthetic-sparing effect |
| 11/24/2010 | CN101896204A Compositions and methods for treating purpura |
| 11/24/2010 | CN101896180A Combination 059 |
| 11/24/2010 | CN101896177A Combinations of therapeutic agents for treating cancer |
| 11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/24/2010 | CN101890165A Composition for lowering blood pressure and application thereof |
| 11/24/2010 | CN101890164A Method for laser preparation of nano-drug preparation |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890135A Antidepressant traditional Chinese medicine composition and application thereof |
| 11/23/2010 | US7838648 Purified SR-p70 protein |
| 11/23/2010 | US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 11/23/2010 | US7838563 Compounds, formulations, and methods for ameliorating telangiectasias |
| 11/23/2010 | US7838557 treating an allergic reaction by topically administering a therapeutically effective amount of an X-ray contrast medium comprising a triiodinated benzene moiety that is completely or partially substituted, and where contrast medium is a non-ionic or ionic monomer, a non-ionic or ionic dimer |
| 11/23/2010 | US7838511 With a phospholipid such as dipalmitoyl phosphatidylcholine, and an antiinflammatory drug such as a nonsteroidal, anti-inflammatory drug (NSAID) such as celecoxib |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/23/2010 | US7838024 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive |
| 11/23/2010 | US7838020 Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least one matrix metalloproteinase inhibitor |
| 11/23/2010 | US7838019 Use of iscom particle(s) as adjuvant in a formulation of vaccine antigens, which comprise at least one iscom-iscom matrix particle together with a non-replicating vaccine antigen and one or more living micro-organisms; enhanced immune response against live vaccine components |
| 11/23/2010 | US7838018 Quaternary hydrocarbon ammonium halogenide and monophosphoryl lipid; synergistic potentiation; kits; tuberculosis |
| 11/23/2010 | US7837997 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 11/23/2010 | US7837987 Fusion using polyoxyalkylene glycol |
| 11/23/2010 | US7836883 Methods for treating rhinitis and conjunctivitis |
| 11/23/2010 | CA2547378C Edible compositions which are adapted for use by a companion animal |
| 11/23/2010 | CA2516642C Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors |
| 11/23/2010 | CA2487489C Mitotic kinesin inhibitors |
| 11/23/2010 | CA2385150C Vascular coating composition |
| 11/23/2010 | CA2373302C Conditioned cell culture medium compositions and methods of use |
| 11/23/2010 | CA2354148C Aerosol formulations for buccal and pulmonary application |
| 11/23/2010 | CA2342200C Use of certain drugs for treating nerve root injury |
| 11/23/2010 | CA2194501C Method of regulating immune function |
| 11/18/2010 | WO2010132867A1 Vaccine immunotherapy |
| 11/18/2010 | WO2010132423A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors |
| 11/18/2010 | WO2010131491A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody |
| 11/18/2010 | WO2010130779A2 COMBINATION OF A PBOSPBOINOSITKLE 3-KSπASE INHIBITOR AND AN ANTIDIABETIC COMPOUND |
| 11/18/2010 | WO2010130468A1 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity |
| 11/18/2010 | WO2010130462A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 11/18/2010 | WO2010076564A3 Isochromenones useful in the treatment of inflammation |
| 11/18/2010 | WO2010071866A3 Combination therapy for arthritis with tranilast |
| 11/18/2010 | US20100292456 Rna interference mediating small rna molecules |
| 11/18/2010 | US20100292314 Anti-angiogenic compositions and methods of use |
| 11/18/2010 | US20100291678 Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses |
| 11/18/2010 | US20100291203 Opioid Agonist/Antagonist Combinations |
| 11/18/2010 | US20100291170 Novel therapies for chronic renal failure |
| 11/18/2010 | US20100291121 Tumour-Specific Animal Proteins |
| 11/18/2010 | US20100291102 Therapeutic Agent |
| 11/18/2010 | US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases |
| 11/18/2010 | US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 11/18/2010 | DE102009021372A1 Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 11/18/2010 | CA2761740A1 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 11/18/2010 | CA2761716A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors |
| 11/18/2010 | CA2761628A1 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity |
| 11/18/2010 | CA2760179A1 Combination of a phosphoinositide 3-kinase inhibitor and an antidiabetic compound |
| 11/17/2010 | EP2251695A2 Markers associated with endometrial disease |
| 11/17/2010 | EP2251355A1 Treatment with anti-VEGF antibodies |
| 11/17/2010 | EP2251350A2 RORalpha promoting the induction of Bmal1 |
| 11/17/2010 | EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| 11/17/2010 | EP2251017A1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 11/17/2010 | EP2251014A1 Combined use of cholestanol derivative |
| 11/17/2010 | EP2251007A2 Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases |
| 11/17/2010 | EP2251003A2 Ophthalmic Compositions for the Re-epithelialization, Healing and Disinfection of the Eye Tissues |